Current Edition

Ther 2
Therapeutics V8 I3

Considerations for Performing Sweat Testing In a Cystic Fibrosis Clinical Trial

Sweat testing was initially standardised in 1959 and it remains the gold standard for diagnosing cystic fibrosis (CF). Guidelines from the US Cystic Fibrosis Foundation …

Continue Reading →
Ther 1
Therapeutics V8 I3

Improving Development of Antiepileptic Drugs for Rare Forms of Epilepsy

Jayne Abraham, PhD, Director of Medical and Scientific Affairs for Neuroscience at Worldwide Clinical Trials Therapeutic and Idil Çavuş, MD PhD is a Senior Medical …

Continue Reading →